Yesterday, RDM reported its Q2, 2015 results. The company earned (U.S.) $789,000 on revenue of $5.75-million.
“Growth in both our recurring payment processing and digital imaging revenue translated into increased profitability in the quarter,” said CEO Randy Fowlie. “In addition, we continue to see evidence of strong market acceptance this quarter with two new financial institutions selecting RDM to replace existing RDC providers.” “One is a top 30 United States bank and the other is a large international bank. We look forward to partnering with these two new customers going forward.”
Sangha thinks the two new customers in the quarter are contributing to what he sees as an EBITDA growth story. The analyst is forecasting Adjusted EBITDA growth of 36% in fiscal 2015 and 11% the following year.
“We believe RDM will continue to improve margins and profitability as the Company shifts towards greater recurring revenue and transactional-based services, leading to a higher share price,” said Sangha.
In a research update to clients yesterday, Sangha moved his recommendation on RDM Corp. to “Buy” from “Neutral” and raised his one year target price on the stock to $4.50, from $3.80.
It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]
Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]
Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]
Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]
The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]
Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]